Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm

Purpose of reviewHIV and pathogenic simian immunodeficiency virus infection are characterized by chronic immune activation. This review addresses the factors that influence immune activation and may thus determine the rate of disease progression during the asymptomatic period of HIV. Recent findingsImmune activation stems from foreign antigen stimulation, including HIV, microbial products and coinfections and compensatory homeostatic mechanisms. Continuous immune stimulation creates a permissive environment for further viral replication, while temporarily allowing successful replenishment of the T-cell pool. Type I interferon, microbial translocation, activated (but ineffective) effector T cells, unruly regulatory T cells and inadequate T helper 17 cells all play important roles in the cycle of activation, functional exhaustion and T-cell death that leads to immunodeficiency. SummaryThe asymptomatic chronic phase of HIV infection is a dynamic balance between host and virus, the outcome of which determines an individual's course of disease. Evaluation of the factors that determine the immunologic threshold of disease progression could assist in designing therapeutic strategies, including individualized timing of ART.

[1]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[2]  R. Kaul,et al.  Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract , 2007, AIDS.

[3]  R. Detels,et al.  Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T‐cell measurements , 1998, AIDS.

[4]  Richard A. Lempicki,et al.  Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV , 2001, The Journal of experimental medicine.

[5]  D. Fuchs,et al.  HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. , 2007, Blood.

[6]  D. Richman,et al.  CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals , 2008, Nature Medicine.

[7]  R. Sékaly,et al.  Reversible Blockade of Thymic Output: An Inherent Part of TLR Ligand-Mediated Immune Response1 , 2008, The Journal of Immunology.

[8]  R. Sékaly,et al.  TLR Ligand-Induced Type I IFNs Affect Thymopoiesis1 , 2008, The Journal of Immunology.

[9]  M. Zeitz,et al.  Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group. , 1995, Gut.

[10]  M. Lederman,et al.  A potential role for interleukin-7 in T-cell homeostasis. , 2001, Blood.

[11]  G. Gao,et al.  PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. , 2007, Blood.

[12]  R. Koup,et al.  Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. , 2003, Immunity.

[13]  J. Lifson,et al.  HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. , 2008, The Journal of clinical investigation.

[14]  Jiyuan Zhang,et al.  The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV‐1‐infected typical progressors, but not in long‐term non‐progressors , 2009, Immunology.

[15]  M. Cooper,et al.  Impairment of  T and B Cell Development by Treatment with a Type I Interferon , 1998, The Journal of experimental medicine.

[16]  Wei Wang,et al.  Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals , 2008, The Journal of experimental medicine.

[17]  M. Zeitz,et al.  HIV/SIV Enteropathy , 1998, Annals of the New York Academy of Sciences.

[18]  R. Siliciano,et al.  Severe Depletion of CD4+ CD25+ Regulatory T Cells from the Intestinal Lamina Propria but Not Peripheral Blood or Lymph Nodes during Acute Simian Immunodeficiency Virus Infection , 2007, Journal of Virology.

[19]  M. Lederman,et al.  Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T cell receptor engagement. , 2005, The Journal of infectious diseases.

[20]  J. Metcalf,et al.  Idiopathic CD4 (cid:1) lymphocytopenia: natural history and prognostic factors , 2008 .

[21]  Amalio Telenti,et al.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 , 2007, Nature Genetics.

[22]  R. Detels,et al.  Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection. , 1998, The Journal of infectious diseases.

[23]  H. McClure,et al.  Coinfection with Schistosoma mansoni Reactivates Viremia in Rhesus Macaques with Chronic Simian-Human Immunodeficiency Virus Clade C Infection , 2007, Infection and Immunity.

[24]  D. Follmann,et al.  HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells , 2008, Proceedings of the National Academy of Sciences.

[25]  R. Dewar,et al.  Differential antiviral effect of PEG-interferon-α-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients , 2007, AIDS.

[26]  J. Carlis,et al.  Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. , 2007, The Journal of infectious diseases.

[27]  R. Grant,et al.  Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis , 2001, Nature Medicine.

[28]  R. Siliciano,et al.  Severe Depletion of CD 4 CD 25 Regulatory T Cells from the Intestinal Lamina Propria but Not Peripheral Blood or Lymph Nodes during Acute Simian Immunodeficiency Virus Infection , 2007 .

[29]  Devan V Mehrotra,et al.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial , 2008, The Lancet.

[30]  R. Detels,et al.  Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. , 1993, Journal of acquired immune deficiency syndromes.

[31]  S. Dandekar Pathogenesis of HIV in the gastrointestinal tract , 2007, Current HIV/AIDS reports.

[32]  P. Zoltick,et al.  FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity. , 2008, Virology.

[33]  Liguo Zhang,et al.  FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo. , 2008, Blood.

[34]  D. Price,et al.  CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[35]  A. Mocroft,et al.  Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  R. Detels,et al.  Serum beta2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T‐cell fall and prognosis , 1990, AIDS.

[37]  Mark S. Sundrud,et al.  HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells , 2004, PLoS biology.

[38]  P. Marrack,et al.  Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. , 2007, The Journal of clinical investigation.

[39]  Z. Bentwich,et al.  HIV and helminth co‐infection: is deworming necessary? , 2006, Parasite immunology.

[40]  C. Sabin,et al.  CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up. , 1993, AIDS.

[41]  S. Gringhuis,et al.  TNF-α and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo , 2008 .

[42]  Lewis H Kuller,et al.  Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.

[43]  F. Villinger,et al.  CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys Produce More IL-2 Than Cells from Disease-Susceptible Species: Involvement of p300 and CREB at the Proximal IL-2 Promoter in IL-2 Up-Regulation1 , 2007, The Journal of Immunology.

[44]  J. Metcalf,et al.  Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial. , 1990, Annals of internal medicine.

[45]  R. Kaul,et al.  Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection , 2008, The Journal of experimental medicine.

[46]  P. Lebon,et al.  Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression. , 2008, Blood.

[47]  L. Greller,et al.  Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells , 2007, The Journal of experimental medicine.

[48]  Tanya M. Teslovich,et al.  Chronic CD4+ T-Cell Activation and Depletion in Human Immunodeficiency Virus Type 1 Infection: Type I Interferon-Mediated Disruption of T-Cell Dynamics , 2007, Journal of Virology.

[49]  D. Douek,et al.  Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia. , 2009, The Journal of infectious diseases.

[50]  J. Montaner,et al.  Susceptibility to AIDS progression appears early in HIV infection , 1990, AIDS.

[51]  J. Lieberman,et al.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.

[52]  D. Hom,et al.  Impact of tuberculosis (TB) on HIV‐1 activity in dually infected patients , 2001, Clinical and experimental immunology.

[53]  A. Fauci,et al.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. , 1983, The New England journal of medicine.

[54]  T. Chun,et al.  HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[55]  F. Miedema,et al.  Abundance of Early Functional HIV-Specific CD8+ T Cells Does Not Predict AIDS-Free Survival Time , 2008, PloS one.

[56]  Jeffrey N. Martin,et al.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. , 2008, The Journal of infectious diseases.

[57]  Alan S. Perelson,et al.  Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen , 1998, The Journal of experimental medicine.

[58]  Aarti Gautam,et al.  Cutting Edge: Experimentally Induced Immune Activation in Natural Hosts of Simian Immunodeficiency Virus Induces Significant Increases in Viral Replication and CD4+ T Cell Depletion1 , 2008, The Journal of Immunology.

[59]  R. Dersimonian,et al.  Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. , 2003, Journal of acquired immune deficiency syndromes.

[60]  G. Boucher,et al.  Transcription factor FOXO3a controls the persistence of memory CD4+ T cells during HIV infection , 2008, Nature Medicine.

[61]  H. Fried Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction , 2007 .

[62]  P. E. Simonsen,et al.  Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial. , 2007, The American journal of tropical medicine and hygiene.

[63]  G. Freeman,et al.  Enhancing SIV-Specific Immunity In Vivo by PD-1 Blockade , 2008, Nature.

[64]  J. Nielsen,et al.  Regulatory T cells in human immunodeficiency virus‐infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti‐retroviral therapy , 2008, Clinical and experimental immunology.

[65]  A S Perelson,et al.  Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. , 1998, Science.

[66]  John Sidney,et al.  Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection , 2007, Nature Medicine.

[67]  C. Chougnet,et al.  HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. , 2006, Blood.

[68]  Christine Hogan,et al.  Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[69]  Judith N. Mandl,et al.  Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections , 2008, Nature Medicine.

[70]  N. Jones,et al.  Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation1 , 2005, The Journal of Immunology.

[71]  David R Bangsberg,et al.  Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. , 2006, JAMA.

[72]  C. Hallahan,et al.  HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors , 2002, Nature Immunology.

[73]  Jay K Kolls,et al.  Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut , 2008, Nature Medicine.

[74]  H. Stellbrink,et al.  Increased Interferon Alpha Expression in Circulating Plasmacytoid Dendritic Cells of HIV-1-Infected Patients , 2008, Journal of acquired immune deficiency syndromes.

[75]  M. Lederman,et al.  Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. , 2007, Blood.

[76]  A. Boasso,et al.  HIV-Induced Type I Interferon and Tryptophan Catabolism Drive T Cell Dysfunction Despite Phenotypic Activation , 2008, PloS one.

[77]  A. Haase,et al.  Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys. , 2008, The Journal of clinical investigation.

[78]  A. Boasso,et al.  Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. , 2008, Clinical immunology.

[79]  F. Barré-Sinoussi,et al.  Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. , 2005, The Journal of clinical investigation.

[80]  Antonio Polley,et al.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection , 2009, Nature Immunology.

[81]  Mardge H. Cohen,et al.  CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus. , 2008, The Journal of infectious diseases.

[82]  D. Watkins,et al.  Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. , 2006, The Journal of infectious diseases.

[83]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[84]  J. Sprent,et al.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection , 2005, The Journal of experimental medicine.

[85]  A. Kelleher,et al.  Regulatory T cells in HIV infection: Who’s suppressing what? , 2008, Current HIV/AIDS reports.

[86]  Rob J. de Boer,et al.  Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection , 2000, Nature Medicine.

[87]  J. Overbaugh,et al.  Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial , 2008, AIDS.

[88]  H. Stein,et al.  Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. , 2006, Blood.

[89]  Eva Chung,et al.  HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells , 2008, Nature Immunology.

[90]  F. Miedema,et al.  Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection , 2004, AIDS.

[91]  J M Taylor,et al.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. , 1990, The New England journal of medicine.

[92]  G. Pantaleo,et al.  Activation of a dendritic cell–T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells , 2008, The Journal of experimental medicine.

[93]  A. Haase,et al.  Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count , 2005, AIDS.

[94]  F. Miedema,et al.  Persistent immune activation in HIV-1 infection is associated with progression to AIDS , 2003, AIDS.

[95]  Z. Grossman,et al.  The Journal of Experimental Medicine , 2000 .

[96]  R. Siliciano,et al.  Preservation of FoxP3+ Regulatory T Cells in the Peripheral Blood of Human Immunodeficiency Virus Type 1-Infected Elite Suppressors Correlates with Low CD4+ T-Cell Activation , 2008, Journal of Virology.

[97]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[98]  D. Douek,et al.  Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques , 2008, Mucosal Immunology.

[99]  D. Douek,et al.  Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. , 2008, Blood.

[100]  J. Metcalf,et al.  Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. , 2008, Blood.

[101]  J. Flamm,et al.  Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.

[102]  J. Fahey,et al.  Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[103]  J. Metcalf,et al.  Interferon-α in patients with asymptomatic human immunodeficiency virus (HIV) infection. , 1990 .

[104]  A. Lawson,et al.  The Loss of Telomerase Activity in Highly Differentiated CD8+CD28−CD27− T Cells Is Associated with Decreased Akt (Ser473) Phosphorylation1 , 2007, The Journal of Immunology.

[105]  R. Lempicki,et al.  Human Immunodeficiency Virus Viremia Induces Plasmacytoid Dendritic Cell Activation In Vivo and Diminished Alpha Interferon Production In Vitro , 2008, Journal of Virology.

[106]  M. Carrington,et al.  Genetic Control of Variegated KIR Gene Expression: Polymorphisms of the Bi-Directional KIR3DL1 Promoter Are Associated with Distinct Frequencies of Gene Expression , 2007, PLoS Genetics.

[107]  R. Balderas,et al.  Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction , 2006, Nature Medicine.

[108]  A. Kelleher,et al.  Regulatory T cells in HIV infection: Who’s suppressing what? , 2008, Current infectious disease reports.

[109]  A. Perelson,et al.  Acute Loss of Intestinal CD4+ T Cells Is Not Predictive of Simian Immunodeficiency Virus Virulence1 , 2007, The Journal of Immunology.

[110]  F Miedema,et al.  T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). , 2000, Blood.

[111]  C. Hallahan,et al.  Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. , 2008, Immunity.